XML 68 R32.htm IDEA: XBRL DOCUMENT

Stock Option Plan and Stock Based Compensation (Tables)

9 Months Ended

Nov. 30, 2019

Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]

As of November 30, 2019, the Company had no outstanding vested or unvested stock options. The Company had the following stock option activity for the nine months ended November 30, 2019:

						Weighted
				Weighted		Average		Aggregate
	Number			Average		Remaining		Intrinsic
	of Shares			Exercise		Contractual		Value(a)
	(exact quantity)			Price		Life (in years)		(in thousands)
Outstanding at March 1, 2019		61,590		$	15.88		1.8	$	327
Granted		—			—
Terminated		—			—
Exercised		(61,590	)	$	15.88
Outstanding at November 30, 2019		—			—		—		—
Exercisable at November 30, 2019		—			—		—		—

(a)	Intrinsic value is measured as the excess of fair market value of the Company’s common stock as reported on the New York Stock Exchange over the applicable exercise price.

Summary of Stock Options Exercised and Tax Benefits Realized from Stock Based Compensation

A summary of the stock options exercised and tax benefits realized from stock based compensation is presented below (in thousands):

	Three months ended				Nine months ended
	November 30,				November 30,
	2019		2018		2019		2018
Total cash received	$	—	$	—	$	—		69
Income tax benefits		—		—		—		—
Total grant-date fair value		—		—		201		345
Intrinsic value		—		—		267		534

Restricted Stock Activity

The Company had the following restricted stock activity for the nine months ended November 30, 2019:

				Weighted
				Average
	Number of			Grant Date
	Shares			Fair Value
Outstanding at March 1, 2019		155,105		$	19.03
Granted		66,669			20.41
Terminated		(3,920	)		17.02
Vested		(73,928	)		18.90
Outstanding at November 30, 2019		143,926		$	19.79